Physician profile
Sergey Kachur
NPI 1144583998
$41,421.97
in general payments reported to CMS, 2019-2025
37 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,377 · 2020: $4,447 · 2021: $1,871 · 2022: $3,911 · 2023: $1,880 · 2024: $2,314 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $4,659 · Travel and Lodging: $3,192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,964.46 |
| Food and Beverage | $4,659.43 |
| Travel and Lodging | $3,192.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $11,251.67 | 2019-2025 | Repatha |
| Bracco Diagnostics INC. | $8,206.08 | 2025 | |
| Biotronik INC. | $8,086.15 | 2019-2020 | |
| Abbott Laboratories | $6,436.58 | 2019-2025 | Triclip, Mitraclip, Coroflow |
| Siemens Medical Solutions USA, INC. | $1,131.93 | 2022 | |
| Janssen Pharmaceuticals, INC | $859.34 | 2020-2024 | Xarelto |
| Abiomed | $681.64 | 2021-2025 | Impella |
| Astrazeneca Pharmaceuticals LP | $493.20 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $437.94 | 2019-2025 | Lifevest |
| Medtronic, INC. | $424.81 | 2022-2024 | Corevalve Evolut R, Micra |
| Novartis Pharmaceuticals Corporation | $349.00 | 2019-2024 | |
| Edwards Lifesciences Corporation | $280.26 | 2025 | Evoque |
| Pfizer INC. | $260.62 | 2019-2021 | |
| Lantheus Medical Imaging, INC. | $249.10 | 2019-2023 | Definity |
| Astellas Pharma US INC | $236.96 | 2021-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $212.87 | 2022-2025 | Igt Devices Undivided |
| Boehringer Ingelheim Pharmaceuticals, INC. | $194.53 | 2023-2025 | Jardiance |
| Shockwave Medical, INC | $187.21 | 2020-2025 | |
| Ancora Heart, INC. | $178.27 | 2025 | Accucinch |
| Boston Scientific Corporation | $164.49 | 2020-2023 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $153.50 | 2020-2021 | |
| United Therapeutics Corporation | $135.71 | 2025 | |
| Inari Medical, INC. | $130.20 | 2021 | |
| Glaxosmithkline, LLC. | $114.21 | 2019 | |
| Novo Nordisk INC | $110.55 | 2022 | |
| Horizon Therapeutics Plc | $95.44 | 2022 | |
| Esperion Therapeutics, INC. | $90.46 | 2020-2021 | |
| Livanova USA, INC. | $55.21 | 2020 | |
| Janssen Scientific Affairs, LLC | $41.92 | 2021 | |
| Mallinckrodt Hospital Products INC. | $37.24 | 2023 | Acthar |
| Genzyme Corporation | $29.39 | 2025 | |
| Mallinckrodt Enterprises LLC | $19.98 | 2019 | |
| Endotronix, INC. | $19.84 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $18.41 | 2025 | Opsumit |
| Chiesi USA, INC. | $16.74 | 2019 | |
| Irhythm Technologies, INC. | $15.65 | 2024 | Zio Xt Patch |
| Cook Medical LLC | $14.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergey Kachur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.